Cleared Traditional

K882674 - IMMU-MARK(TM) CHLAMYDIA IGG/IGA KIT

K882674 is an FDA 510(k) clearance for IMMU-MARK(TM) CHLAMYDIA IGG/IGA KIT, manufactured by Icn Immunobiologicals. The device is a Class 1 Microbiology device with product code LKH cleared through the Traditional 510(k) pathway after a 413-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1989
Decision
413d
Days
Class 1
Risk

K882674 is an FDA 510(k) clearance for the IMMU-MARK(TM) CHLAMYDIA IGG/IGA KIT. Classified as Antisera, Immunoperoxidase, Chlamydia Spp. (product code LKH), Class I - General Controls.

Submitted by Icn Immunobiologicals (Lisle, US). The FDA issued a Cleared decision on August 15, 1989 after a review of 413 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3120 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Microbiology submissions.

FDA 510(k) Submission Details - K882674

510(k) Number K882674 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 1988
Decision Date August 15, 1989
Days to Decision 413 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
311d slower than avg
Panel avg: 102d · This submission: 413d
Pathway characteristics
Predicate-based equivalence.

LKH Device Classification - Class 1, General Controls

Product Code LKH Antisera, Immunoperoxidase, Chlamydia Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LKH Antisera, Immunoperoxidase, Chlamydia Spp.

All 7
Devices cleared under the same product code (LKH) and FDA review panel - the closest regulatory comparables to K882674.
IPAZYME (TM) CHLAMYDIA IGG-IGA
K910644 · Savyon Diagnostics , Ltd. · Mar 1991
IPAZYME(TM) CHLAMYDIA TRUE IGM(TM)
K901975 · Savyon Diagnostics , Ltd. · Mar 1991
CELLMATICS SHLAMYDIA DETECTION SYSTEM
K893669 · Difco Laboratories, Inc. · Jun 1989
SELECTICULT-CHLAMYDIA
K852869 · Scott Laboratories, Inc. · Sep 1985
CHLAMYDIAE IMMUNOPEROXIDASE TEST KIT
K842151 · Bartels Immunodiagnostic Supplies, Inc. · Jul 1984
COMBION SKIN TEST
K830688 · Nicholas H. Maganias · Mar 1983